$CVS
CVS Health Corp

2013 Q2 Form 10-Q Financial Statement

#000006480313000021 Filed on August 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $31.25B $30.69B
YoY Change 1.8% 16.2%
Cost Of Revenue $25.41B $25.27B
YoY Change 0.56% 18.46%
Gross Profit $5.841B $5.443B
YoY Change 7.31% 7.02%
Gross Profit Margin 18.69% 17.73%
Selling, General & Admin $3.869B $3.741B
YoY Change 3.42% 3.86%
% of Gross Profit 66.24% 68.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.869B $3.741B
YoY Change 3.42% 3.86%
Operating Profit $1.972B $1.702B
YoY Change 15.86% 14.69%
Interest Expense $127.0M $132.0M
YoY Change -3.79% -11.41%
% of Operating Profit 6.44% 7.76%
Other Income/Expense, Net
YoY Change
Pretax Income $1.846B $1.576B
YoY Change 17.13% 17.96%
Income Tax $721.0M $610.0M
% Of Pretax Income 39.06% 38.71%
Net Earnings $1.124B $961.0M
YoY Change 16.96% 17.91%
Net Earnings / Revenue 3.6% 3.13%
Basic Earnings Per Share $0.92 $0.75
Diluted Earnings Per Share $0.91 $0.75
COMMON SHARES
Basic Shares Outstanding 1.227B shares 1.278B shares
Diluted Shares Outstanding 1.236B shares 1.287B shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.179B $1.828B
YoY Change -35.5% -18.14%
Cash & Equivalents $1.174B $1.823B
Short-Term Investments $5.000M $5.000M
Other Short-Term Assets $413.0M $919.0M
YoY Change -55.06% 10.86%
Inventory $10.58B $10.43B
Prepaid Expenses
Receivables $7.093B $6.124B
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.87B $19.30B
YoY Change 2.95% 1.23%
LONG-TERM ASSETS
Property, Plant & Equipment $8.708B $8.614B
YoY Change 1.09% 1.54%
Goodwill $26.55B $26.43B
YoY Change 0.49%
Intangibles $9.657B
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.496B $1.360B
YoY Change 10.0% 11.48%
Total Long-Term Assets $46.42B $46.29B
YoY Change 0.27% -0.28%
TOTAL ASSETS
Total Short-Term Assets $19.87B $19.30B
Total Long-Term Assets $46.42B $46.29B
Total Assets $66.28B $65.59B
YoY Change 1.06% 0.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.178B $8.551B
YoY Change -39.45% 13.91%
Accrued Expenses $3.501B $4.380B
YoY Change -20.07% 31.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $200.0M
YoY Change -100.0%
Long-Term Debt Due $18.00M $5.000M
YoY Change 260.0% -99.45%
Total Short-Term Liabilities $12.69B $13.14B
YoY Change -3.4% 11.78%
LONG-TERM LIABILITIES
Long-Term Debt $9.358B $9.208B
YoY Change 1.63% -9.44%
Other Long-Term Liabilities $1.534B $1.438B
YoY Change 6.68% 7.07%
Total Long-Term Liabilities $10.89B $10.65B
YoY Change 2.31% -7.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.69B $13.14B
Total Long-Term Liabilities $10.89B $10.65B
Total Liabilities $23.58B $27.68B
YoY Change -14.79% 1.59%
SHAREHOLDERS EQUITY
Retained Earnings $26.57B
YoY Change
Common Stock $17.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.99B
YoY Change
Treasury Stock Shares 448.0M shares 385.0M shares
Shareholders Equity $38.91B $37.91B
YoY Change
Total Liabilities & Shareholders Equity $66.28B $65.59B
YoY Change 1.06% 0.16%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $1.124B $961.0M
YoY Change 16.96% 17.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $902.0M $1.231B
YoY Change -26.73% 1.99%
INVESTING ACTIVITIES
Capital Expenditures -$486.0M -$442.0M
YoY Change 9.95% 10.22%
Acquisitions
YoY Change
Other Investing Activities -$40.00M -$200.0M
YoY Change -80.0% -85.36%
Cash From Investing Activities -$526.0M -$642.0M
YoY Change -18.07% -63.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -751.0M -977.0M
YoY Change -23.13% -256.07%
NET CHANGE
Cash From Operating Activities 902.0M 1.231B
Cash From Investing Activities -526.0M -642.0M
Cash From Financing Activities -751.0M -977.0M
Net Change In Cash -375.0M -388.0M
YoY Change -3.35% -687.88%
FREE CASH FLOW
Cash From Operating Activities $902.0M $1.231B
Capital Expenditures -$486.0M -$442.0M
Free Cash Flow $1.388B $1.673B
YoY Change -17.04% 4.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5178000000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5070000000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7093000000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6473000000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3501000000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4051000000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-181000000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-182000000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29120000000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29532000000 USD
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000 shares
CY2013Q2 us-gaap Assets
Assets
66284000000 USD
CY2012Q4 us-gaap Assets
Assets
65912000000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
19869000000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
19852000000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1174000000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1375000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1413000000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1823000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-201000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
410000000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.325
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2250
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2012Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2013Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2012Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2013Q2 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1667000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1676000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1227000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1231000000 shares
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
34000000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
17000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1741000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1105000000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
965000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2060000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2060000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1105000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1743000000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
966000000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
25412000000 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
25265000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
50950000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
50593000000 USD
CY2013Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
9400000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
663000000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
606000000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3796000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3784000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
951000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
854000000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
8000000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
26554000000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
26395000000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
5836000000 USD
us-gaap Gross Profit
GrossProfit
11418000000 USD
us-gaap Gross Profit
GrossProfit
10562000000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
5449000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
967000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1122000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2078000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1744000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1576000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2848000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3415000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1842000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1742000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
966000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2078000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1122000000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.76
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.91
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.35
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.69
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.68
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.75
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.91
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2000000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
720000000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
610000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1337000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1106000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
924000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1530000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
655000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
98000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
575000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-412000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1095000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
527000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-204000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
181000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
138000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-165000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-254000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9657000000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9753000000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
132000000 USD
us-gaap Interest Expense
InterestExpense
264000000 USD
us-gaap Interest Expense
InterestExpense
254000000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
127000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-263000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-252000000 USD
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-126000000 USD
CY2012Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-132000000 USD
us-gaap Interest Paid
InterestPaid
281000000 USD
us-gaap Interest Paid
InterestPaid
267000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
10759000000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
10578000000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66284000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65912000000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13790000000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12690000000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
18000000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000 USD
CY2013Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
10300000000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9358000000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9133000000 USD
CY2003Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 entity
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2522000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1648000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1085000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1093000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4017000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2542000000 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
966000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2077000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1742000000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1121000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
3741000000 USD
us-gaap Operating Expenses
OperatingExpenses
7751000000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3868000000 USD
us-gaap Operating Expenses
OperatingExpenses
7451000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3111000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3667000000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1708000000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1968000000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8632000000 USD
CY2013Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
10000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16000000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
577000000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
413000000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1280000000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1496000000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1501000000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1534000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
748000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
553000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
420000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
300000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
274000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
818000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
804000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
44657000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
45289000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7134000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7452000000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
56446000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
57644000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
1000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-550000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-690000000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7000000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
309000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
518000000 USD
us-gaap Profit Loss
ProfitLoss
2077000000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
965000000 USD
us-gaap Profit Loss
ProfitLoss
1740000000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
1121000000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8708000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
23000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
18000000 USD
CY2012Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
54000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2012Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
8000000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
18000000 USD
CY2013Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
10000000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
13000000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26573000000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25049000000 USD
CY2013Q2 us-gaap Revenues
Revenues
31248000000 USD
CY2012Q2 us-gaap Revenues
Revenues
30714000000 USD
us-gaap Revenues
Revenues
61512000000 USD
us-gaap Revenues
Revenues
62011000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
66000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
64000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8000000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.45
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.63
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
54.54
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M5D
CY2013Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2012Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
690000000 USD
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
48000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
51000000 USD
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
20000000 USD
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
22000000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38906000000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37704000000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
435000000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
448000000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
16270000000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
16987000000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1238000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1298000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1236000000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1287000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1289000000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1278000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1230000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1227000000 shares
CY2013Q2 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3993000000 USD
CY2012Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3974000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
83000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
82000000 USD
CY2013Q2 cvs Guaranteed Store Leases
GuaranteedStoreLeases
74 store_lease
CY2013Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2012Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Intersegment Transactions Number Of Type Of Transactions
IntersegmentTransactionsNumberOfTypeOfTransactions
2 type_of_transaction
cvs Minimum Initial Maturities Of Short Term Investments
MinimumInitialMaturitiesOfShortTermInvestments
P3M
CY2003Q4 cvs Number Of Competitors Against Whom Putative Actions Are Filed
NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled
2 competitor
CY2003Q4 cvs Number Of Pharmacies Filing Putative Action
NumberOfPharmaciesFilingPutativeAction
2 pharmacy
CY2013Q2 cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-16000000 USD
cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-18000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
0 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
26000000 USD
cvs Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1600000000 USD
CY2013Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1100000000 USD
CY2012Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
840000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
2000000000 USD
dei Amendment Flag
AmendmentFlag
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1228369418 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CVS CAREMARK CORPORATION

Files In Submission

Name View Source Status
0000064803-13-000021-index-headers.html Edgar Link pending
0000064803-13-000021-index.html Edgar Link pending
0000064803-13-000021.txt Edgar Link pending
0000064803-13-000021-xbrl.zip Edgar Link pending
cvs-20130630.xml Edgar Link completed
cvs-20130630.xsd Edgar Link pending
cvs-20130630_cal.xml Edgar Link unprocessable
cvs-20130630_def.xml Edgar Link unprocessable
cvs-20130630_lab.xml Edgar Link unprocessable
cvs-20130630_pre.xml Edgar Link unprocessable
cvs20130630-10q.htm Edgar Link pending
cvs20130630ex311.htm Edgar Link pending
cvs20130630ex312.htm Edgar Link pending
cvs20130630ex321.htm Edgar Link pending
cvs20130630ex322.htm Edgar Link pending
cvs2013arcreditagreem_image1.gif Edgar Link pending
cvs2013creditagreemen_image1.gif Edgar Link pending
exhibit101fiveyearcreditag.htm Edgar Link pending
exhibit102amendedcreditagr.htm Edgar Link pending
exhibit151q2eyconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending